2025年全球體外診斷市場報告

預計未來幾年體外診斷試劑的市場規模將快速成長。到 2029 年，這一數字將成長至 2,326.9 億美元，複合年成長率為 11.8%。預測期內的成長將受到精準醫療、就地檢驗、數位健康和​​數據分析以及大流行病防範的推動。預測期內的主要趨勢包括技術進步、數位健康整合、個人化診斷、家用檢測套組和分子診斷。

未來幾年，自我管理檢測套組的日益普及將推動體外診斷市場的擴張。這些檢測套組專為個人使用而設計，這意味著測試不需要由醫療保健專業人員或受過培訓的人員進行，人們可以在家中進行診斷評估。這種可近性和便利性的提高可能會導致檢測需求的增加，特別是對以前可能未被發現的疾病。例如，美國疾病管制與預防中心 2022 年美國的統計數據顯示，美國18 歲及以上成年人使用家庭 COVID-19 檢測的人數大幅增加。將Delta主導時期（2021 年 8 月至 12 月）與 Omicron 主導時期（2022 年 12 月至 3 月）進行比較，在出現類似 COVID-19 症狀的受訪者中，在家檢測的使用率顯著增加，從 5.7% 上升到 20.1%。因此，自我管理檢測套組的日益普及預計將推動體外診斷市場的成長。

由於預計癌症盛行率將會增加，體外診斷市場預計會擴大。癌症包括 100 多種疾病，可出現在身體的不同部位，其特徵是細胞不受控制的生長和擴散。體外診斷 (IVD) 包括分析人體樣本的測試和醫療設備，以提供癌症篩檢、診斷和治療所需的資訊。例如，2023年1月，美國國家生物技術資訊中心預測，2023年美國將有1,958,310例新發癌症病例和609,820例癌症相關死亡病例。因此，預計癌症發生率將會增加，從而推動體外診斷市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 世界體外診斷PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球體外診斷市場：成長率分析
• 全球體外診斷市場表現：規模與成長，2019-2024
• 全球體外診斷市場預測：規模與成長，2024-2029 年，2034 年
• 體外診斷全球總目標市場（TAM）

第6章市場區隔

• 全球體外診斷市場類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
• 2019-2024 年、2024-2029 年、2034 年全球體外診斷市場支出（按類型、實際支出和預測）
• 全球體外診斷市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 全球體外診斷市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 全球體外診斷市場，依照護現場診斷器材與設備類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球體外診斷市場免疫化學診斷儀器和設備按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 全球體外診斷市場臨床化學診斷儀器與設備細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球體外診斷市場分子診斷儀器和設備按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 全球體外診斷市場微生物診斷儀器和設備按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 全球體外診斷市場，依凝血診斷器材與設備類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球體外診斷市場血液學診斷儀器與設備細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球體外診斷市場免疫血液學診斷器材與設備按類型、性能和預測進行細分，2019-2024 年、2024-2029 年、2034 年

第7章 區域和國家分析

• 全球體外診斷市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球體外診斷市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 孟加拉市場

第16章 泰國市場

第17章 越南市場

第18章 馬來西亞市場

第19章 新加坡市場

第20章：菲律賓市場

第21章 香港市場

第22章：紐西蘭市場

第23章 西歐市場

第24章英國市場

第25章 德國市場

第26章 法國市場

第27章：義大利市場

第28章 西班牙市場

第29章：西班牙市場

第30章 奧地利市場

第31章 比利時市場

第32章 丹麥市場

第33章 芬蘭市場

第34章 愛爾蘭市場

第35章 荷蘭市場

第36章 挪威市場

In vitro diagnostics (IVD) are tests performed on biological samples, such as blood, tissue, or urine, collected from the human body to identify diseases, conditions, or infections. Conducted outside the body in controlled environments like laboratories, these tests utilize specialized equipment and reagents. IVDs play a vital role in diagnosing various health conditions, guiding treatment decisions, and monitoring patient health over time.

The principal categories of in-vitro diagnostics equipment encompass point-of-care diagnostics devices and equipment, immunochemistry diagnostic devices and equipment, clinical chemistry diagnostics devices and equipment, molecular diagnostics devices and equipment, microbiology diagnostic devices and equipment, hemostasis diagnostic devices and equipment, hematology diagnostic devices and equipment, and immunohematology diagnostic devices and equipment. Hematology instruments, for instance, are machines designed to analyze blood samples, perform blood counts, detect proteins or enzymes, and aid in the diagnosis of diseases or genetic defects. These devices and equipment are used in both public and private settings and involve instruments/equipment as well as disposables. The end-users for these tools include hospitals and clinics, diagnostic laboratories, and other relevant institutions.

The in-vitro diagnostics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides in-vitro diagnostics devices and equipment market statistics, including in-vitro diagnostics devices and equipment industry global market size, regional shares, competitors with an in-vitro diagnostics devices and equipment market share, detailed in-vitro diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro diagnostics devices and equipment industry. This in-vitro diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro diagnostics market size has grown rapidly in recent years. It will grow from $130.74 billion in 2024 to $149.01 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to the development of automated analyzers and molecular diagnostics, aging population, disease outbreaks, healthcare regulations, personalized medicine.

The in-vitro diagnostics market size is expected to see rapid growth in the next few years. It will grow to $232.69 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to precision medicine, point-of-care testing, digital health and data analytics, pandemic preparedness. Major trends in the forecast period include technological advancements, digital health integration, personalized diagnostics, home testing kits, molecular diagnostics.

The growing adoption of self-administered test kits is set to fuel the expansion of the in vitro diagnostics market in the forthcoming years. These kits are designed for self-use, eliminating the necessity for medical professionals or trained individuals to conduct the tests, allowing people to perform diagnostic evaluations at their residences. This increased accessibility and convenience could potentially result in a higher demand for testing, especially for conditions that may have previously gone undetected. For example, statistics from the Centers for Disease Control and Prevention in April 2022 exhibited a significant surge in the use of at-home COVID-19 tests among adults aged 18 and older in the United States. Comparing the Delta-dominant period (August to December 2021) to the Omicron-dominant period (December to March 2022), there was a notable increase in at-home test utilization among respondents experiencing symptoms resembling COVID-19, rising from 5.7% to 20.1%. Hence, the increasing adoption of self-administered test kits is anticipated to be a driving factor in the growth of the in vitro diagnostics market.

The projected rise in the prevalence of cancer is expected to drive the expansion of the in vitro diagnostics market. Cancer comprises a wide array of over 100 diseases that can manifest in various parts of the body, characterized by the uncontrolled proliferation and dissemination of cells. In vitro diagnostics (IVDs) encompass tests or medical devices that analyze samples obtained from the human body, providing vital information for the screening, diagnosis, and treatment of cancer. For instance, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, projected that there would be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States for the year 2023. Consequently, the anticipated rise in cancer prevalence is set to drive the growth of the in vitro diagnostics market.

Key companies in the in vitro diagnostics market are focusing on the development of innovative products to drive their market growth, such as the Cobas pulse system. This system is a professional blood glucose management solution equipped with mobile digital health capabilities to enhance patient care. For example, in January 2022, Roche Diagnostics, a US-based company specializing in innovative products and services addressing disease prevention, diagnosis, monitoring, screening, and treatment, introduced the Cobas pulse system. This portable device comprises an automated glucose test strip reader, a camera, and a touchscreen for capturing additional diagnostic data. Its user-friendly interface is designed for seamless integration, providing convenient functionalities that optimize processes, save time, and improve operational workflows.

Major players in the in vitro diagnostics (IVD) market are incorporating advanced technologies, such as UIMG image technology and 2D decoder chips, to enhance diagnostic accuracy and efficiency, improve data analysis, optimize workflows, and ultimately deliver better patient outcomes. UIMG image technology is an advanced imaging technique used in diagnostics to capture and analyze high-resolution images, enhancing the visualization and interpretation of biological samples. For example, in November 2023, Newland, a Netherlands-based technology company in the EMEA region, launched a new IVD product line. This product line includes five barcode scanners that are compact, durable, and designed to optimize automated diagnostic processes, aiming to boost diagnostic speed and accuracy in response to the growing demand for efficient healthcare solutions.

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMerieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

North America was the largest region in the global in-vitro diagnostics market in 2024. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the in vitro diagnostics market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The in-vitro diagnostics devices and equipment market consist of sales of kits, reagents, piece of software, system, and instrument. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Point-of-Care Diagnostics Devices And Equipment; Immunochemistry Diagnostic Devices And Equipment; Clinical Chemistry Diagnostics Devices And Equipment; Molecular Diagnostics Devices And Equipment; Microbiology Diagnostic Devices And Equipment; Hemostasis Diagnostic Devices And Equipment; Hematology Diagnostic Devices And Equipment; Immunohematology Diagnostic Devices And Equipment
• 2) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
• 3) By Type of Expenditure: Public; Private
• 4) By Product: Instruments/Equipment; Disposables
• Subsegments:
• 1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring; Pregnancy And Fertility Testing; Infectious Disease Testing; Cardiac Markers Testing; Coagulation Testing
• 2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA); Western Blot; Immunofluorescence Assay; Chemiluminescence Immunoassay (CLIA)
• 3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing; Cholesterol Testing; Liver Function Testing; Kidney Function Testing; Electrolyte Testing
• 4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments; Next-Generation Sequencing (NGS) Instruments; Microarray Instruments; FISH (Fluorescence In Situ Hybridization) Devices
• 5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems; Automated Identification Systems; Antimicrobial Susceptibility Testing Systems; Blood Culture Systems
• 6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers; Thromboelastography Systems; Platelet Function Analyzers; Clotting Factor Analyzers
• 7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers; Hemoglobin Testing Systems; Complete Blood Count (CBC) Devices; Blood Cell Counters
• 8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems; Crossmatching Systems; Antibody Screening Systems; Blood Bank Analyzers
• Companies Mentioned: Siemens Healthineers; F. Hoffmann-La Roche AG; Danaher Corporation; Abbott Laboratories Inc.; Thermo Fisher Scientific Inc.
• Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostics Market Characteristics

3. In Vitro Diagnostics Market Trends And Strategies

4. In Vitro Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global In Vitro Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global In Vitro Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global In Vitro Diagnostics Market Growth Rate Analysis
• 5.4. Global In Vitro Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global In Vitro Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global In Vitro Diagnostics Total Addressable Market (TAM)

6. In Vitro Diagnostics Market Segmentation

• 6.1. Global In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.2. Global In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.3. Global In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.4. Global In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.5. Global In Vitro Diagnostics Market, Sub-Segmentation Of Point-of-Care Diagnostics Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.6. Global In Vitro Diagnostics Market, Sub-Segmentation Of Immunochemistry Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.7. Global In Vitro Diagnostics Market, Sub-Segmentation Of Clinical Chemistry Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.8. Global In Vitro Diagnostics Market, Sub-Segmentation Of Molecular Diagnostics Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.9. Global In Vitro Diagnostics Market, Sub-Segmentation Of Microbiology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.10. Global In Vitro Diagnostics Market, Sub-Segmentation Of Hemostasis Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.11. Global In Vitro Diagnostics Market, Sub-Segmentation Of Hematology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.12. Global In Vitro Diagnostics Market, Sub-Segmentation Of Immunohematology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7. In Vitro Diagnostics Market Regional And Country Analysis

• 7.1. Global In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Vitro Diagnostics Market

• 8.1. Asia-Pacific In Vitro Diagnostics Market Overview
• 8.2. Asia-Pacific In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Vitro Diagnostics Market

• 9.1. China In Vitro Diagnostics Market Overview
• 9.2. China In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Vitro Diagnostics Market

• 10.1. India In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Vitro Diagnostics Market

• 11.1. Japan In Vitro Diagnostics Market Overview
• 11.2. Japan In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Vitro Diagnostics Market

• 12.1. Australia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Vitro Diagnostics Market

• 13.1. Indonesia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Vitro Diagnostics Market

• 14.1. South Korea In Vitro Diagnostics Market Overview
• 14.2. South Korea In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Bangladesh In Vitro Diagnostics Market

• 15.1. Bangladesh In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Bangladesh In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Bangladesh In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. Thailand In Vitro Diagnostics Market

• 16.1. Thailand In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. Thailand In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. Thailand In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Vietnam In Vitro Diagnostics Market

• 17.1. Vietnam In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Vietnam In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Vietnam In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. Malaysia In Vitro Diagnostics Market

• 18.1. Malaysia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. Malaysia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. Malaysia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Singapore In Vitro Diagnostics Market

• 19.1. Singapore In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Singapore In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Singapore In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Philippines In Vitro Diagnostics Market

• 20.1. Philippines In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Philippines In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Philippines In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Hong Kong In Vitro Diagnostics Market

• 21.1. Hong Kong In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.2. Hong Kong In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Hong Kong In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. New Zealand In Vitro Diagnostics Market

• 22.1. New Zealand In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. New Zealand In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. New Zealand In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. Western Europe In Vitro Diagnostics Market

• 23.1. Western Europe In Vitro Diagnostics Market Overview
• 23.2. Western Europe In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. Western Europe In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. Western Europe In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. UK In Vitro Diagnostics Market

• 24.1. UK In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.2. UK In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. UK In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Germany In Vitro Diagnostics Market

• 25.1. Germany In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.2. Germany In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Germany In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. France In Vitro Diagnostics Market

• 26.1. France In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.2. France In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. France In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Italy In Vitro Diagnostics Market

• 27.1. Italy In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Italy In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Italy In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Spain In Vitro Diagnostics Market

• 28.1. Spain In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.2. Spain In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Spain In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Spain In Vitro Diagnostics Market

• 29.1. Spain In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.2. Spain In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Spain In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Austria In Vitro Diagnostics Market

• 30.1. Austria In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 30.2. Austria In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 30.3. Austria In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

31. Belgium In Vitro Diagnostics Market

• 31.1. Belgium In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 31.2. Belgium In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 31.3. Belgium In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

32. Denmark In Vitro Diagnostics Market

• 32.1. Denmark In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 32.2. Denmark In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 32.3. Denmark In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

33. Finland In Vitro Diagnostics Market

• 33.1. Finland In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 33.2. Finland In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 33.3. Finland In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

34. Ireland In Vitro Diagnostics Market

• 34.1. Ireland In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 34.2. Ireland In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 34.3. Ireland In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

35. Netherlands In Vitro Diagnostics Market

• 35.1. Netherlands In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 35.2. Netherlands In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 35.3. Netherlands In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

36. Norway In Vitro Diagnostics Market

• 36.1. Norway In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 36.2. Norway In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic a